PIK3CB and gastric cancer: Although the exact genomic changes that occur in mTOR signaling downstream of PI3K/Akt are not well clarified, it is reported that phosphorylated-mTOR overexpression is related to some clinicopathological features and poor prognosis in GC patients alone or combined with TSC1 downregulation [139,140].